The BALB/c. mdx 62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.050502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Kristy Swiderski und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Muscle Research, Department of Anatomy and Physiology, The University of Melbourne, Melbourne, VIC 3010, Australia. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Disease Models, Animal, Mice, Inbred BALB C, Dystrophin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, University of Melbourne.
Abstract (Originalsprache)
Duchenne muscular dystrophy (DMD) is a devastating monogenic skeletal muscle-wasting disorder. Although many pharmacological and genetic interventions have been reported in preclinical studies, few have progressed to clinical trials with meaningful benefit. Identifying therapeutic potential can be limited by availability of suitable preclinical mouse models. More rigorous testing across models with varied background strains and mutations can identify treatments for clinical success. Here, we report the generation of a DMD mouse model with a CRISPR-induced deletion within exon 62 of the dystrophin gene (Dmd) and the first generated in BALB/c mice. Analysis of mice at 3, 6 and 12 months of age confirmed loss of expression of the dystrophin protein isoform Dp427 and resultant dystrophic pathology in limb muscles and the diaphragm, with evidence of centrally nucleated fibers, increased inflammatory markers and fibrosis, progressive decline in muscle function, and compromised trabecular bone development. The BALB/c.mdx62 mouse is a novel model of DMD with associated variations in the immune response and muscle phenotype, compared with those of existing models. It represents an important addition to the preclinical model toolbox for developing therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Muscle Research, Department of Anatomy and Physiology, The University of Melbourne, Melbourne, VIC 3010, Australia.
- The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
- Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, Australia.
- Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
- School of Cancer Medicine, La Trobe University, Heidelberg, VIC 3084, Australia.
ORCID-Profile: Gordon S Lynch
Förderung
- National Health and Medical Research Council
- University of Melbourne
Zitieren
APA
Swiderski, K., Chan, A. S., Herold, M. J., Kueh, A. J., Chung, J. D., Hardee, J. P., Trieu, J., Chee, A., Naim, T., Gregorevic, P., & Lynch, G. S. (2024). The BALB/c. mdx 62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050502
Vancouver
Swiderski K, Chan AS, Herold MJ, Kueh AJ, Chung JD, Hardee JP, et al. The BALB/c. mdx 62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050502
BibTeX
@article{Swiderski2024,
author = {Swiderski, Kristy and Chan, Audrey S and Herold, Marco J and Kueh, Andrew J and Chung, Jin D and Hardee, Justin P and Trieu, Jennifer and Chee, Annabel and Naim, Timur and Gregorevic, Paul and Lynch, Gordon S},
title = {The BALB/c. mdx 62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.050502}
}
EUVIMED